Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04197336 · ClinicalTrials.gov registry record · NA

Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT04197336: Completed NA study, sponsored by Johns Hopkins University.

NCT04197336 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04197336, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The BEATLES study is an investigator-initiated, prospective, double-blinded, randomized, sham-controlled study that will assess the impact of bariatric embolization on the systemic levels of obesity-related hormones and, as a consequence, on weight loss. The goal of this study is to help treat obesity combining a lifestyle program and a minimally invasive, angiographic (i.e., through blood vessels) approach.

Primary Outcome

Efficacy of Bariatric Embolization procedure assessed by change in body weight as assessed by BMI.

Interventions

  • DEVICE Bariatric Embolization of Arteries with imaging visible Embolics

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2020-01-10
Est. Completion 2023-12-14
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT04197336 record still lists

NCT04197336 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Bariatric Embolization of Arteries with imaging visible Embolics is the first listed.

NCT04197336 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04197336 about?

NCT04197336 is a clinical study titled "Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)". The BEATLES study is an investigator-initiated, prospective, double-blinded, randomized, sham-controlled study that will assess the impact of bariatric embolization on the systemic levels of obesity-related hormones and, as a consequence, on weight loss. The goal of this study is to help treat obesi...

What is the current status of trial NCT04197336?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-01-10. Estimated completion is 2023-12-14.

What interventions are being tested in trial NCT04197336?

The interventions under investigation include: Bariatric Embolization of Arteries with imaging visible Embolics (DEVICE).

Who is sponsoring clinical trial NCT04197336?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04197336's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04197336, the US trial registry maintained by the National Library of Medicine. NCT04197336 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.